AQUAX DEO- aluminum chlorohydrate cream 
Pella Pharmaceuticals Co. Ltd

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Deo

Forms and presentation

Cream: Tube of 75 g

Active Ingredient

Aluminum Chlorohydrate

Inactive Ingredients

Aqua, Cetearyl Alcohol, Ceteareth-22, Glycerin, Petrolatum, Ceteareth-25, Sodium Citrate, Methylparaben, Citric Acid, Parfum, Propylparaben.

Purpose

Antiperspirant

Properties

Aquax ® Deo cream reduces excessive sweating (hyperhidrosis)

Indications

Aquax ® Deo cream is used to reduce excessive perspiraton (hyperhidrosis)

Precautions

keep out of reach of children

Warnings

Contraindications

Hypersensitivity to any of the components

Side effects

Aquax ® Deo cream has no known side effect, its us is without risk

Dosage and administration

Dry the area to be treated, and then apply Aquax ® Deo cream at night, at bed time

Storage conditions

Store at a temperature belwo 30 °C

Primary Package

Primary Package

Secondary Package

Secondary Package

AQUAX DEO 
aluminum chlorohydrate cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:82160-313
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ALUMINUM CHLOROHYDRATE (UNII: HPN8MZW13M) (ALUMINUM CHLOROHYDRATE - UNII:HPN8MZW13M) ALUMINUM CHLOROHYDRATE150 mg  in 75 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
CETEARETH-22 (UNII: 28VZG1E234)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
PETROLATUM (UNII: 4T6H12BN9U)  
CETEARETH-25 (UNII: 8FA93U5T67)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82160-313-011 in 1 CARTON03/15/2011
175 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35003/15/2011
Labeler - Pella Pharmaceuticals Co. Ltd (562370925)

Revised: 11/2021
Document Id: d19b9a37-a05b-3de4-e053-2a95a90a50a8
Set id: d19b9a37-a05a-3de4-e053-2a95a90a50a8
Version: 313
Effective Time: 20211125
 
Pella Pharmaceuticals Co. Ltd